Reata Pharma Raises $78 Million
Reata Pharmaceuticals Inc., an Irving, Texas-based developer of oral anti-inflammatory drugs, has raised $78 million in new VC funding. Return backers CPMG Inc. and Novo AS co-led the round. Reata Pharma now has raised more than $180 million in total VC funding since its 2002 inception.
12 July 2010•3 mins read
